Glucagon-Like Peptide-1 Receptor Agonists to Expand the Healthy Lifespan: Current and Future Potentials
Ahrn B, Masmiquel L, Kumar H et al (2017) Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial
(2022) 14:1759720X211073001
By understanding the safety and tackling the doubts, we can see the full picture of LifeWave X39
Seek urgent medical advice if you experience: Severe allergic reactions (anaphylaxis): difficulty breathing, swelling of the face, lips, tongue or throat, severe rash, or feeling faintthese require immediate emergency care (call 999)